nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Ageusia—Rivastigmine—Alzheimer's disease	0.0255	0.0433	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Donepezil—Alzheimer's disease	0.0147	0.025	CcSEcCtD
Methylscopolamine bromide—Tension—Galantamine—Alzheimer's disease	0.0129	0.0219	CcSEcCtD
Methylscopolamine bromide—Nervousness—Galantamine—Alzheimer's disease	0.0127	0.0216	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Galantamine—Alzheimer's disease	0.0124	0.021	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Memantine—Alzheimer's disease	0.0122	0.0207	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.0119	0.0203	CcSEcCtD
Methylscopolamine bromide—Palpitations—Galantamine—Alzheimer's disease	0.0116	0.0197	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Rivastigmine—Alzheimer's disease	0.0115	0.0196	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Galantamine—Alzheimer's disease	0.0109	0.0186	CcSEcCtD
Methylscopolamine bromide—Confusional state—Galantamine—Alzheimer's disease	0.0108	0.0183	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Galantamine—Alzheimer's disease	0.0104	0.0178	CcSEcCtD
Methylscopolamine bromide—Tension—Donepezil—Alzheimer's disease	0.00997	0.017	CcSEcCtD
Methylscopolamine bromide—Nervousness—Donepezil—Alzheimer's disease	0.00986	0.0168	CcSEcCtD
Methylscopolamine bromide—Insomnia—Galantamine—Alzheimer's disease	0.00967	0.0165	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Donepezil—Alzheimer's disease	0.00957	0.0163	CcSEcCtD
Methylscopolamine bromide—Somnolence—Galantamine—Alzheimer's disease	0.00951	0.0162	CcSEcCtD
Methylscopolamine bromide—Constipation—Galantamine—Alzheimer's disease	0.00915	0.0156	CcSEcCtD
Methylscopolamine bromide—Tension—Memantine—Alzheimer's disease	0.00905	0.0154	CcSEcCtD
Methylscopolamine bromide—Nervousness—Memantine—Alzheimer's disease	0.00896	0.0152	CcSEcCtD
Methylscopolamine bromide—Tension—Rivastigmine—Alzheimer's disease	0.00885	0.0151	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Galantamine—Alzheimer's disease	0.00881	0.015	CcSEcCtD
Methylscopolamine bromide—Nervousness—Rivastigmine—Alzheimer's disease	0.00876	0.0149	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Memantine—Alzheimer's disease	0.00869	0.0148	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Rivastigmine—Alzheimer's disease	0.0085	0.0145	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Donepezil—Alzheimer's disease	0.00846	0.0144	CcSEcCtD
Methylscopolamine bromide—Confusional state—Donepezil—Alzheimer's disease	0.00836	0.0142	CcSEcCtD
Methylscopolamine bromide—CHRM2—forebrain—Alzheimer's disease	0.00823	0.0876	CbGeAlD
Methylscopolamine bromide—Palpitations—Memantine—Alzheimer's disease	0.00815	0.0139	CcSEcCtD
Methylscopolamine bromide—Palpitations—Rivastigmine—Alzheimer's disease	0.00797	0.0136	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Galantamine—Alzheimer's disease	0.00788	0.0134	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Memantine—Alzheimer's disease	0.00768	0.0131	CcSEcCtD
Methylscopolamine bromide—Asthenia—Galantamine—Alzheimer's disease	0.00767	0.0131	CcSEcCtD
Methylscopolamine bromide—Confusional state—Memantine—Alzheimer's disease	0.00759	0.0129	CcSEcCtD
Methylscopolamine bromide—CHRM2—telencephalon—Alzheimer's disease	0.00757	0.0805	CbGeAlD
Methylscopolamine bromide—Dry mouth—Rivastigmine—Alzheimer's disease	0.00751	0.0128	CcSEcCtD
Methylscopolamine bromide—Insomnia—Donepezil—Alzheimer's disease	0.0075	0.0128	CcSEcCtD
Methylscopolamine bromide—CHRM1—forebrain—Alzheimer's disease	0.00749	0.0797	CbGeAlD
Methylscopolamine bromide—Confusional state—Rivastigmine—Alzheimer's disease	0.00742	0.0126	CcSEcCtD
Methylscopolamine bromide—Somnolence—Donepezil—Alzheimer's disease	0.00737	0.0125	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Memantine—Alzheimer's disease	0.00735	0.0125	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Rivastigmine—Alzheimer's disease	0.00719	0.0122	CcSEcCtD
Methylscopolamine bromide—Constipation—Donepezil—Alzheimer's disease	0.00709	0.0121	CcSEcCtD
Methylscopolamine bromide—Dizziness—Galantamine—Alzheimer's disease	0.00707	0.012	CcSEcCtD
Methylscopolamine bromide—CHRM1—telencephalon—Alzheimer's disease	0.00689	0.0733	CbGeAlD
Methylscopolamine bromide—Feeling abnormal—Donepezil—Alzheimer's disease	0.00683	0.0116	CcSEcCtD
Methylscopolamine bromide—Insomnia—Memantine—Alzheimer's disease	0.00681	0.0116	CcSEcCtD
Methylscopolamine bromide—Vomiting—Galantamine—Alzheimer's disease	0.0068	0.0116	CcSEcCtD
Methylscopolamine bromide—CHRM3—forebrain—Alzheimer's disease	0.0067	0.0713	CbGeAlD
Methylscopolamine bromide—Headache—Galantamine—Alzheimer's disease	0.0067	0.0114	CcSEcCtD
Methylscopolamine bromide—Somnolence—Memantine—Alzheimer's disease	0.00669	0.0114	CcSEcCtD
Methylscopolamine bromide—Insomnia—Rivastigmine—Alzheimer's disease	0.00666	0.0113	CcSEcCtD
Methylscopolamine bromide—Urticaria—Donepezil—Alzheimer's disease	0.00659	0.0112	CcSEcCtD
Methylscopolamine bromide—Somnolence—Rivastigmine—Alzheimer's disease	0.00655	0.0111	CcSEcCtD
Methylscopolamine bromide—CHRM5—nervous system—Alzheimer's disease	0.00651	0.0693	CbGeAlD
Methylscopolamine bromide—Tiotropium—CYP2D6—Alzheimer's disease	0.00645	0.655	CrCbGaD
Methylscopolamine bromide—Constipation—Memantine—Alzheimer's disease	0.00644	0.0109	CcSEcCtD
Methylscopolamine bromide—Nausea—Galantamine—Alzheimer's disease	0.00635	0.0108	CcSEcCtD
Methylscopolamine bromide—Constipation—Rivastigmine—Alzheimer's disease	0.0063	0.0107	CcSEcCtD
Methylscopolamine bromide—CHRM5—central nervous system—Alzheimer's disease	0.00627	0.0667	CbGeAlD
Methylscopolamine bromide—Feeling abnormal—Memantine—Alzheimer's disease	0.0062	0.0105	CcSEcCtD
Methylscopolamine bromide—CHRM3—telencephalon—Alzheimer's disease	0.00616	0.0656	CbGeAlD
Methylscopolamine bromide—Hypersensitivity—Donepezil—Alzheimer's disease	0.00611	0.0104	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00607	0.0103	CcSEcCtD
Methylscopolamine bromide—Urticaria—Memantine—Alzheimer's disease	0.00598	0.0102	CcSEcCtD
Methylscopolamine bromide—Asthenia—Donepezil—Alzheimer's disease	0.00595	0.0101	CcSEcCtD
Methylscopolamine bromide—Urticaria—Rivastigmine—Alzheimer's disease	0.00585	0.00995	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Memantine—Alzheimer's disease	0.00555	0.00943	CcSEcCtD
Methylscopolamine bromide—Dizziness—Donepezil—Alzheimer's disease	0.00548	0.00932	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00542	0.00923	CcSEcCtD
Methylscopolamine bromide—Asthenia—Memantine—Alzheimer's disease	0.0054	0.00918	CcSEcCtD
Methylscopolamine bromide—Asthenia—Rivastigmine—Alzheimer's disease	0.00528	0.00898	CcSEcCtD
Methylscopolamine bromide—Vomiting—Donepezil—Alzheimer's disease	0.00527	0.00896	CcSEcCtD
Methylscopolamine bromide—Headache—Donepezil—Alzheimer's disease	0.00519	0.00883	CcSEcCtD
Methylscopolamine bromide—Dizziness—Memantine—Alzheimer's disease	0.00498	0.00847	CcSEcCtD
Methylscopolamine bromide—CHRM5—brain—Alzheimer's disease	0.00498	0.0529	CbGeAlD
Methylscopolamine bromide—Nausea—Donepezil—Alzheimer's disease	0.00492	0.00837	CcSEcCtD
Methylscopolamine bromide—Dizziness—Rivastigmine—Alzheimer's disease	0.00487	0.00828	CcSEcCtD
Methylscopolamine bromide—Vomiting—Memantine—Alzheimer's disease	0.00479	0.00814	CcSEcCtD
Methylscopolamine bromide—Headache—Memantine—Alzheimer's disease	0.00472	0.00802	CcSEcCtD
Methylscopolamine bromide—Vomiting—Rivastigmine—Alzheimer's disease	0.00468	0.00796	CcSEcCtD
Methylscopolamine bromide—Headache—Rivastigmine—Alzheimer's disease	0.00461	0.00785	CcSEcCtD
Methylscopolamine bromide—Nausea—Memantine—Alzheimer's disease	0.00447	0.0076	CcSEcCtD
Methylscopolamine bromide—CHRM2—nervous system—Alzheimer's disease	0.00447	0.0475	CbGeAlD
Methylscopolamine bromide—Nausea—Rivastigmine—Alzheimer's disease	0.00437	0.00744	CcSEcCtD
Methylscopolamine bromide—CHRM2—central nervous system—Alzheimer's disease	0.0043	0.0458	CbGeAlD
Methylscopolamine bromide—CHRM1—nervous system—Alzheimer's disease	0.00407	0.0433	CbGeAlD
Methylscopolamine bromide—CHRM1—central nervous system—Alzheimer's disease	0.00392	0.0417	CbGeAlD
Methylscopolamine bromide—CHRM3—nervous system—Alzheimer's disease	0.00364	0.0387	CbGeAlD
Methylscopolamine bromide—CHRM3—central nervous system—Alzheimer's disease	0.0035	0.0373	CbGeAlD
Methylscopolamine bromide—CHRM2—brain—Alzheimer's disease	0.00342	0.0363	CbGeAlD
Methylscopolamine bromide—Ipratropium bromide—CYP2D6—Alzheimer's disease	0.00339	0.344	CrCbGaD
Methylscopolamine bromide—CHRM1—brain—Alzheimer's disease	0.00311	0.0331	CbGeAlD
Methylscopolamine bromide—CHRM3—brain—Alzheimer's disease	0.00278	0.0296	CbGeAlD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GAL—Alzheimer's disease	0.000197	0.000639	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GFAP—Alzheimer's disease	0.000197	0.000639	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GFAP—Alzheimer's disease	0.000196	0.000637	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GAL—Alzheimer's disease	0.000196	0.000637	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	0.000194	0.00063	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	0.000194	0.00063	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SST—Alzheimer's disease	0.000192	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GAB2—Alzheimer's disease	0.000192	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NTRK2—Alzheimer's disease	0.000192	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CALM1—Alzheimer's disease	0.000191	0.000619	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GSK3A—Alzheimer's disease	0.00019	0.000616	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APP—Alzheimer's disease	0.000187	0.000606	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—Alzheimer's disease	0.000182	0.000591	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ACHE—Alzheimer's disease	0.00018	0.000584	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—F2—Alzheimer's disease	0.000179	0.000582	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INPP5D—Alzheimer's disease	0.000178	0.000577	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PLCB1—Alzheimer's disease	0.000176	0.000572	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—A2M—Alzheimer's disease	0.000173	0.000563	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—A2M—Alzheimer's disease	0.000173	0.000561	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000173	0.00056	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000172	0.000559	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	0.000171	0.000556	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000171	0.000555	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.00017	0.000553	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000169	0.000548	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ENO1—Alzheimer's disease	0.000169	0.000547	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS1—Alzheimer's disease	0.000169	0.000547	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000168	0.000545	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PSEN2—Alzheimer's disease	0.000167	0.000543	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000166	0.000538	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYP2D6—Alzheimer's disease	0.000165	0.000536	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGFR—Alzheimer's disease	0.000164	0.000533	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CREB1—Alzheimer's disease	0.000163	0.00053	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000162	0.000526	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000162	0.000524	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADAM10—Alzheimer's disease	0.000161	0.000521	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.00016	0.000519	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL2—Alzheimer's disease	0.00016	0.000519	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000159	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000158	0.000513	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—BCHE—Alzheimer's disease	0.000157	0.000508	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000157	0.000508	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000155	0.000504	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000155	0.000502	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NPY—Alzheimer's disease	0.000155	0.000502	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NPY—Alzheimer's disease	0.000154	0.0005	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IAPP—Alzheimer's disease	0.000154	0.000499	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000153	0.000497	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IAPP—Alzheimer's disease	0.000153	0.000497	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	0.000153	0.000495	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—S100B—Alzheimer's disease	0.000152	0.000493	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	0.000152	0.000492	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CRH—Alzheimer's disease	0.000149	0.000484	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CRH—Alzheimer's disease	0.000149	0.000482	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PLCB1—Alzheimer's disease	0.000148	0.00048	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	0.000147	0.000478	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000147	0.000477	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR5—Alzheimer's disease	0.000147	0.000476	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	0.000145	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF2—Alzheimer's disease	0.000145	0.000469	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000144	0.000467	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000144	0.000466	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ABCA1—Alzheimer's disease	0.000143	0.000465	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000142	0.000461	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	0.000141	0.000459	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NPS—Alzheimer's disease	0.000141	0.000457	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000141	0.000457	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00014	0.000455	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1R—Alzheimer's disease	0.00014	0.000453	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	0.00014	0.000453	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	0.000139	0.000451	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000139	0.000451	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000139	0.00045	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—F2—Alzheimer's disease	0.000139	0.00045	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTK2B—Alzheimer's disease	0.000138	0.000449	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	0.000137	0.000445	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	0.000137	0.000444	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	0.000135	0.000438	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SST—Alzheimer's disease	0.000135	0.000438	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000135	0.000438	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GAB2—Alzheimer's disease	0.000134	0.000436	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SST—Alzheimer's disease	0.000134	0.000436	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NTRK2—Alzheimer's disease	0.000134	0.000436	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000134	0.000436	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LPL—Alzheimer's disease	0.000134	0.000435	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CALM1—Alzheimer's disease	0.000134	0.000435	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000134	0.000434	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GSK3A—Alzheimer's disease	0.000133	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SST—Alzheimer's disease	0.000133	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	0.000133	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	0.000133	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MEF2C—Alzheimer's disease	0.000133	0.000431	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	0.000133	0.00043	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	0.000132	0.000428	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APP—Alzheimer's disease	0.000131	0.000427	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APP—Alzheimer's disease	0.000131	0.000425	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PRKCG—Alzheimer's disease	0.00013	0.000423	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APP—Alzheimer's disease	0.00013	0.000421	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NGF—Alzheimer's disease	0.000127	0.000412	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	0.000126	0.00041	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—F2—Alzheimer's disease	0.000126	0.000408	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	0.000125	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000124	0.000402	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PLCB1—Alzheimer's disease	0.000124	0.000401	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARGC1A—Alzheimer's disease	0.000124	0.000401	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR5—Alzheimer's disease	0.000123	0.000401	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—HMOX1—Alzheimer's disease	0.000123	0.000399	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	0.000122	0.000397	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR2A—Alzheimer's disease	0.000121	0.000392	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	0.000116	0.000376	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGFR—Alzheimer's disease	0.000115	0.000374	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	0.000115	0.000373	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CREB1—Alzheimer's disease	0.000115	0.000372	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	0.000114	0.000371	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	0.000114	0.000368	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	0.000113	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CALM1—Alzheimer's disease	0.000113	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADAM10—Alzheimer's disease	0.000113	0.000366	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	0.000113	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—LPL—Alzheimer's disease	0.000112	0.000365	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—Alzheimer's disease	0.000112	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LEP—Alzheimer's disease	0.000112	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—Alzheimer's disease	0.000112	0.000364	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	0.000112	0.000362	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CAV1—Alzheimer's disease	0.000111	0.000361	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	0.000111	0.00036	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ESR1—Alzheimer's disease	0.000107	0.000348	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	0.000107	0.000347	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—S100B—Alzheimer's disease	0.000107	0.000346	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—F2—Alzheimer's disease	0.000106	0.000344	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	0.000106	0.000342	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000104	0.000336	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	0.000102	0.00033	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF2—Alzheimer's disease	0.000101	0.000329	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—Alzheimer's disease	0.000101	0.000329	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	0.0001	0.000326	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	9.84e-05	0.000319	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1R—Alzheimer's disease	9.81e-05	0.000318	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GSK3B—Alzheimer's disease	9.73e-05	0.000316	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	9.71e-05	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CREB1—Alzheimer's disease	9.65e-05	0.000313	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—INS—Alzheimer's disease	9.6e-05	0.000311	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CALM1—Alzheimer's disease	9.46e-05	0.000307	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—Alzheimer's disease	9.44e-05	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	9.44e-05	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—Alzheimer's disease	9.43e-05	0.000306	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	9.41e-05	0.000305	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	9.35e-05	0.000303	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CAV1—Alzheimer's disease	9.34e-05	0.000303	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	9.32e-05	0.000302	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	9.31e-05	0.000302	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—Alzheimer's disease	9.28e-05	0.000301	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	9.23e-05	0.000299	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	9.17e-05	0.000298	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	9.14e-05	0.000297	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	9.06e-05	0.000294	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	8.94e-05	0.00029	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	8.91e-05	0.000289	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	8.82e-05	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	8.69e-05	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	8.67e-05	0.000281	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	8.58e-05	0.000278	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	8.51e-05	0.000276	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	8.48e-05	0.000275	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	8.41e-05	0.000273	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	8.4e-05	0.000272	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PPARG—Alzheimer's disease	8.21e-05	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—INS—Alzheimer's disease	8.05e-05	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	7.94e-05	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	7.91e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	7.91e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	7.91e-05	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	7.88e-05	0.000256	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	7.88e-05	0.000256	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	7.84e-05	0.000254	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	7.83e-05	0.000254	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	7.81e-05	0.000253	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	7.81e-05	0.000253	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	7.81e-05	0.000253	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	7.74e-05	0.000251	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	7.55e-05	0.000245	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	7.53e-05	0.000244	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—F2—Alzheimer's disease	7.46e-05	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	7.45e-05	0.000242	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—F2—Alzheimer's disease	7.43e-05	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—F2—Alzheimer's disease	7.36e-05	0.000239	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.3e-05	0.000237	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	7.28e-05	0.000236	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	7.21e-05	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	7.2e-05	0.000234	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	7.14e-05	0.000232	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	7.1e-05	0.00023	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—NOS3—Alzheimer's disease	7.06e-05	0.000229	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	6.85e-05	0.000222	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	6.83e-05	0.000222	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	6.79e-05	0.00022	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	6.77e-05	0.00022	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	6.76e-05	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—INS—Alzheimer's disease	6.76e-05	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—INS—Alzheimer's disease	6.73e-05	0.000219	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	6.71e-05	0.000218	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—INS—Alzheimer's disease	6.67e-05	0.000216	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	6.65e-05	0.000216	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	6.63e-05	0.000215	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	6.57e-05	0.000213	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	6.56e-05	0.000213	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	6.55e-05	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	6.54e-05	0.000212	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	6.51e-05	0.000211	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PTGS2—Alzheimer's disease	6.46e-05	0.00021	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	6.45e-05	0.000209	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	6.06e-05	0.000197	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	5.93e-05	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	5.91e-05	0.000192	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	5.85e-05	0.00019	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	5.56e-05	0.000181	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.08e-05	0.000165	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	5.06e-05	0.000164	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	5.03e-05	0.000163	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	5.01e-05	0.000163	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.01e-05	0.000163	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	5e-05	0.000162	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	4.98e-05	0.000162	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	4.97e-05	0.000161	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.93e-05	0.00016	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	4.62e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	4.61e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	4.61e-05	0.00015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	4.6e-05	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	4.58e-05	0.000149	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	4.56e-05	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	4.55e-05	0.000148	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	4.27e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	4.26e-05	0.000138	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	4.21e-05	0.000137	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	4.19e-05	0.000136	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.92e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	3.91e-05	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	3.87e-05	0.000126	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.87e-05	0.000125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AKT1—Alzheimer's disease	3.25e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	3.23e-05	0.000105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	3.22e-05	0.000104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	3.18e-05	0.000103	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.95e-05	9.58e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	2.94e-05	9.55e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.91e-05	9.46e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.72e-05	8.84e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	2.71e-05	8.81e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.69e-05	8.72e-05	CbGpPWpGaD
